NO20021815L - Forbindelse - Google Patents

Forbindelse

Info

Publication number
NO20021815L
NO20021815L NO20021815A NO20021815A NO20021815L NO 20021815 L NO20021815 L NO 20021815L NO 20021815 A NO20021815 A NO 20021815A NO 20021815 A NO20021815 A NO 20021815A NO 20021815 L NO20021815 L NO 20021815L
Authority
NO
Norway
Prior art keywords
connection
Prior art date
Application number
NO20021815A
Other languages
English (en)
Other versions
NO20021815D0 (no
NO327145B1 (no
Inventor
Lisbeth Illum
Peter Watts
Alan Smith
Ian Lafferty
Original Assignee
West Pharm Serv Drug Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by West Pharm Serv Drug Res Ltd filed Critical West Pharm Serv Drug Res Ltd
Publication of NO20021815D0 publication Critical patent/NO20021815D0/no
Publication of NO20021815L publication Critical patent/NO20021815L/no
Publication of NO327145B1 publication Critical patent/NO327145B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C07D489/04—Salts; Organic complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
NO20021815A 1999-10-20 2002-04-17 Blanding for nasal administrasjon omfattende metansulfonat-saltet av morfin og kitosan. NO327145B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9924797.5A GB9924797D0 (en) 1999-10-20 1999-10-20 Compound
PCT/GB2000/004003 WO2001029046A2 (en) 1999-10-20 2000-10-19 A salt of morphine

Publications (3)

Publication Number Publication Date
NO20021815D0 NO20021815D0 (no) 2002-04-17
NO20021815L true NO20021815L (no) 2002-06-14
NO327145B1 NO327145B1 (no) 2009-05-04

Family

ID=10863040

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021815A NO327145B1 (no) 1999-10-20 2002-04-17 Blanding for nasal administrasjon omfattende metansulfonat-saltet av morfin og kitosan.

Country Status (15)

Country Link
US (1) US6387917B1 (no)
EP (1) EP1224188B1 (no)
JP (1) JP4928037B2 (no)
AU (1) AU771616B2 (no)
CA (1) CA2388395C (no)
CY (1) CY1106352T1 (no)
DE (1) DE60033044T2 (no)
DK (1) DK1224188T3 (no)
ES (1) ES2282141T3 (no)
GB (1) GB9924797D0 (no)
NO (1) NO327145B1 (no)
NZ (1) NZ518481A (no)
PT (1) PT1224188E (no)
WO (1) WO2001029046A2 (no)
ZA (1) ZA200203100B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9707934D0 (en) * 1997-04-18 1997-06-04 Danbiosyst Uk Improved delivery of drugs to mucosal surfaces
US7022683B1 (en) * 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US6777000B2 (en) * 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
US20030181488A1 (en) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
US7666876B2 (en) * 2002-03-19 2010-02-23 Vernalis (R&D) Limited Buprenorphine formulations for intranasal delivery
US20040077540A1 (en) * 2002-06-28 2004-04-22 Nastech Pharmaceutical Company Inc. Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds
US20040102476A1 (en) * 2002-11-25 2004-05-27 Chan Tai Wah High concentration formulations of opioids and opioid derivatives
GB0300531D0 (en) * 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
AU2004235744A1 (en) * 2003-05-01 2004-11-18 Archimedes Development Limited Nasal administration of the LH-RH analog leuprolide
GB0315632D0 (en) * 2003-07-04 2003-08-13 West Pharm Serv Drug Res Ltd Pharmaceutical formulations
US20050129679A1 (en) 2003-12-15 2005-06-16 Nastech Pharmaceutical Company Inc. Method for opening tight junctions
US20050175679A1 (en) * 2004-02-10 2005-08-11 Michael Moshman Controlled release formulations
US20150018379A1 (en) 2011-05-13 2015-01-15 Euro-Celtique S.A. Intranasal Pharmaceutical Dosage Forms Comprising Naloxone
US9127008B2 (en) 2013-03-15 2015-09-08 Johnson Matthey Public Limited Company Morphine sulfate methanolic solvate, processes for making same and related compositions and methods for treating pain

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB343397A (en) * 1929-05-24 1931-02-19 Chem Fab Vormals Sandoz Process for the manufacture of easily soluble salts of benzyl morphine
US2665227A (en) 1950-06-30 1954-01-05 Nat Res Corp Apparatus and method of coating by vapor deposition
CH407120A (de) * 1961-03-06 1966-02-15 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen Piperidinderivaten
DE1445518A1 (de) * 1964-01-24 1968-12-05 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen Halogenallylpiperidinen
US4334071A (en) * 1981-02-02 1982-06-08 Miles Laboratories, Inc. 17-Cyclobutylmethyl-3-hydroxy-8β-methyl-6-methylene-morphinane methanesulfonate
US4464378A (en) 1981-04-28 1984-08-07 University Of Kentucky Research Foundation Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
GB9202464D0 (en) * 1992-02-05 1992-03-18 Danbiosyst Uk Composition for nasal administration
ES2194867T3 (es) 1993-03-26 2003-12-01 Franciscus Wilhelmus He Merkus Composiciones farmaceuticas para la administracion intranasal de apomorfina.
EP0623345B1 (en) 1993-05-03 1999-04-14 PHYSION S.r.l. New morphine formulations for use by iontophoretic administration
US5607940A (en) 1994-07-18 1997-03-04 Stephen; Robert L. Morphine formulations for use by electromotive administration
GB9416884D0 (en) * 1994-08-20 1994-10-12 Danbiosyst Uk Drug delivery compositions
JPH09208465A (ja) 1996-02-07 1997-08-12 Takeda Chem Ind Ltd 高濃度注射用モルヒネ液
GB9700624D0 (en) * 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
DE19834005A1 (de) * 1997-09-25 1999-04-01 Lohmann Therapie Syst Lts Säureadditionssalze von Morphin-Alkaloiden und deren Verwendung
PL193321B1 (pl) 1997-09-25 2007-01-31 Lohmann Therapie Syst Lts Sole addycyjne alkaloidu morfinowego z kwasem organicznym, sposób ich wytwarzania, ich zastosowanie do sporządzania preparatów, środek poprzezskórny lub poprzezśluzówkowy do aplikowania tych soli oraz takiż środek do zastosowania jako środek do jontoforezy
WO2000076507A1 (en) 1999-06-16 2000-12-21 Nastech Pharmaceutical Company, Inc. Method for increasing the solubility of morphine and pharmaceutical compositions prepared therefrom
WO2000076477A1 (en) 1999-06-16 2000-12-21 Nastech Pharmaceutical Co., Inc. Methods and compositions for treating breakthrough pain
EP1183027A4 (en) 1999-06-16 2003-02-05 Nastech Pharmaceutical Co PHARMACEUTICAL FORMULATIONS AND METHODS COMPRISING INTRA-NASAL DELIVERY MORPHINE
US6225343B1 (en) 1999-06-16 2001-05-01 Nastech Pharmaceutical Company, Inc. Compositions and methods comprising morphine gluconate

Also Published As

Publication number Publication date
NO20021815D0 (no) 2002-04-17
WO2001029046A3 (en) 2001-11-01
JP4928037B2 (ja) 2012-05-09
EP1224188B1 (en) 2007-01-17
PT1224188E (pt) 2007-02-28
CY1106352T1 (el) 2011-10-12
JP2003512380A (ja) 2003-04-02
ZA200203100B (en) 2003-09-23
WO2001029046A2 (en) 2001-04-26
NO327145B1 (no) 2009-05-04
EP1224188A2 (en) 2002-07-24
GB9924797D0 (en) 1999-12-22
CA2388395C (en) 2010-03-09
NZ518481A (en) 2004-10-29
DK1224188T3 (da) 2007-04-02
AU771616B2 (en) 2004-04-01
ES2282141T3 (es) 2007-10-16
US6387917B1 (en) 2002-05-14
DE60033044T2 (de) 2007-10-18
DE60033044D1 (de) 2007-03-08
CA2388395A1 (en) 2001-04-26
AU7933500A (en) 2001-04-30

Similar Documents

Publication Publication Date Title
DE50010505D1 (de) Gurtaufrollersystem
DE122007000064I2 (de) Erythropoietinkonjugate
DE19983871T1 (de) Fönvorrichtung
DE10084676T1 (de) Einmallanzettvorrichtung
DE50002834D1 (de) Handstempel
ATE357433T1 (de) 4-pyrimidinyl-n-acyl-l-phenylanine
ATE297895T1 (de) 4-pyridinyl-n-acyl-l-phenylalanine
DE50007953D1 (de) Beleuchtungsanordung
NO20021815D0 (no) Forbindelse
DE50008613D1 (de) Sicherungsring
DE50000805D1 (de) Aufsitzspanner
DE10085008T1 (de) Oberflächenbehandlungsdüse
DE50003660D1 (de) Diacylhydrazinderivate
DE50003259D1 (de) Textilie
DE50006013D1 (de) Anschlagpuffer
DE19983890T1 (de) Ventiltaktgebungsjustiereinrichtung
DE50001640D1 (de) Nahfeldoptische untersuchungsvorrichtung
DE50008429D1 (de) Kraftstofffraktioniereinrichtung
DE50006759D1 (de) Piperidinalkohole
DE50006829D1 (de) Benzoylpyridazine
DE10082008D2 (de) Ausbeulgerät
ATE440824T1 (de) Nitro-sulfobenzamide
DE50003283D1 (de) Exzenterspannzwinge
ATA107599A (de) Heizwasserbereiter
DE50002156D1 (de) Azofarbstoffmischungen

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees